EXPRESSION OF PLASMINOGEN ACTIVATORS IN BASAL CELL CARCINOMA
The plasminogen activators, tissue type and urokinase type (tPA and uPA, respectively), have been identified in various malignancies and have been implicated in both local growth and metastatic spread. To characterize plasminogen activator expression more fully in human basal cell carcinoma, the loc...
Saved in:
Published in | The Journal of pathology Vol. 178; no. 3; pp. 290 - 296 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Chichester, UK
John Wiley & Sons, Ltd
01.03.1996
Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The plasminogen activators, tissue type and urokinase type (tPA and uPA, respectively), have been identified in various malignancies and have been implicated in both local growth and metastatic spread. To characterize plasminogen activator expression more fully in human basal cell carcinoma, the localization of uPA and tPA mRNAs was evaluated byin situ hybridization. Nodular basal cell carcinomas demonstrated uPA expression in most cases, whereas the non‐nodular subtypes were negative. Message for uPA was identified within tumour islands (11/12 cases), scattered fibroblast‐like stromal cells (6/12 cases), and the basal layer of the overlying epidermis (10/12 cases). In addition, signal for uPA was elevated and pronounced in areas where the epidermis merged into invasive basal cell carcinoma in the superficial papillary dermis in some cases. Message for uPA was often associated with ulceration or erosion of the overlying epithelium. Expression of tPA was noted in the epidermis (3/12 cases) and in tumour cells (4/12 cases), but tended to be focal and sparse. These results suggest that complex interactions involving uPA expression occur between the tumour, the stroma, and the overlying epidermis. Both the stroma and the epidermis may contribute to local spread of the tumour through production of uPA and consequent plasmin‐mediated activation of collagenases and metalloproteinases. |
---|---|
Bibliography: | National Institute of Health - No. PO1AR39674 istex:357545A6815E02D4EB920B4F98D8D974B91D808F ArticleID:PATH472 ark:/67375/WNG-G7JTFWFF-L ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0022-3417 1096-9896 |
DOI: | 10.1002/(SICI)1096-9896(199603)178:3<290::AID-PATH472>3.0.CO;2-4 |